FDA Considering PET Drug Blanket User Fee Waiver, CDER's Axelrad Says
Executive Summary
PET drug manufacturers may be able to waive user fees under the barrier to innovation provision of the Prescription Drug User Fee Act, Center for Drug Evaluation & Research Associate Director of Policy Jane Axelrad said.